AOD-9604 vs MOTS-C
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of AOD-9604 and MOTS-C (also searched as MOTS-C vs AOD-9604) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
AOD-9604 centers on metabolic, while MOTS-C leans toward metabolic. On indexed research, AOD-9604 is ahead (AOD-9604: 4 studies, Human evidence; MOTS-C: 3, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •AOD-9604 is strongest for metabolic; MOTS-C for metabolic.
- •Evidence: AOD-9604 Human evidence (4 studies) vs MOTS-C Human evidence (3).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
AOD-9604 vs MOTS-C: side-by-side
| Metric | AOD-9604 | MOTS-C |
|---|---|---|
| Class | Weight Loss | Longevity |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 4 | 3 |
| Research level | Well Studied | Well Studied |
| Strongest effect | Metabolic & appetite | Metabolic & appetite |
| Healing & recovery | 3.0▲ | 2.0 |
| Muscle & body comp | 0.0 | 1.0▲ |
| Metabolic & appetite | 4.0▲ | 4.0▲ |
| Neuro & mood | 0.0 | 1.0▲ |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 0.0 | 3.0▲ |
| Skin & aesthetics | 2.0▲ | 0.0 |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | AOD-9604 | MOTS-C |
|---|---|---|
| Mechanism | Modified hGH fragment (176–191) | Mitochondrial-derived peptide; AMPK activation / metabolic regulation |
| Route | Subcutaneous injection (research use) | Subcutaneous injection (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is AOD-9604?
A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.
Full AOD-9604 profile, mechanism & studies →What is MOTS-C?
### Summary MOTS-C is a mitochondrial-derived peptide that has garnered attention for its potential roles in metabolic regulation and cellular stress responses. Emerging research suggests it may have implications in various health conditions, including cardiovascular diseases and placental function.
Full MOTS-C profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | AOD-9604 | 3.0/5 effect signal |
| Muscle | MOTS-C | 1.0/5 effect signal |
| Metabolic | Even | Both ~4.0/5 |
| Neuro | MOTS-C | 1.0/5 effect signal |
| Inflammation | MOTS-C | 3.0/5 effect signal |
| Skin | AOD-9604 | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack AOD-9604 and MOTS-C?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
AOD-9604 vs MOTS-C: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
AOD-9604 has 4 approved studies indexed (Human evidence), and MOTS-C has 3 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is AOD-9604 or MOTS-C better?
It depends on your goal. AOD-9604 is strongest for metabolic; MOTS-C for metabolic. AOD-9604 has more indexed studies (4). See the goal-by-goal breakdown above.
Is AOD-9604 or MOTS-C better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is AOD-9604 or MOTS-C better for muscle?
MOTS-C leads on the muscle & body-composition axis (1.0/5).
Which has more research, AOD-9604 or MOTS-C?
AOD-9604 has 4 approved studies indexed (Human evidence); MOTS-C has 3 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack AOD-9604 and MOTS-C?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of AOD-9604 vs MOTS-C?
AOD-9604: no community-reported effects logged yet. MOTS-C: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is AOD-9604 or MOTS-C FDA-approved?
AOD-9604 is a research-use compound and is not FDA-approved. MOTS-C is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is MOTS-C better than AOD-9604?
For metabolic, MOTS-C has the edge; for metabolic, AOD-9604 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
AOD-9604 and MOTS-C are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.